Excellergy
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $70M
Investors
- 3
About Excellergy
Excellergy Inc. is a US-based biotech company focused on developing innovative therapeutics, specifically Effector Cell Response Inhibitors, targeting severe allergic diseases to improve patient outcomes. Founded in 2022 in Palo Alto, US, Excellergy Inc. specializes in allergy therapeutics, notably Effector Cell Response Inhibitors. Excellergy specializes in pioneering Effector Cell Response Inhibitors (ECRIs) for treating severe allergic diseases. Their products effectively target Immunoglobulin E (IgE) to control allergic responses, focusing on conditions such as allergic asthma and atopic dermatitis. The product line primarily serves healthcare providers and clinics in North America and Europe. Excellergy operates on a B2B revenue model, partnering with healthcare providers for the distribution of their ECRIs. Their flagship product, Exl-111, is central to their sales strategy, which includes negotiated contracts with hospitals emphasizing volume-based pricing and patient outcome reimbursements. In March 2026, Novartis International AG agreed to acquire Excellergy Inc. from Red Tree Venture Capital, Decheng Capital, and Samsara BioCapital for an upfront payment of USD 2 billion and milestone payments.
Who invested in Excellergy
3 investors across 2 rounds
See all investors in Excellergy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Excellergy
Who invested in Excellergy?
Excellergy has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Excellergy raised?
Excellergy has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Excellergy last raise money?
Excellergy's most recent round on record is a Series A, in Oct 2025.
What does Excellergy do?
Excellergy is a biotechnology company.
Where is Excellergy headquartered?
Excellergy is headquartered in Palo Alto, US.
Which VCs invest in companies like Excellergy?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Excellergy's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Excellergy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.